blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3178816

EP3178816 - 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.06.2018
Database last updated on 02.11.2024
FormerThe application has been published
Status updated on  12.05.2017
Most recent event   Tooltip01.06.2018Application deemed to be withdrawnpublished on 04.07.2018  [2018/27]
Applicant(s)For all designated states
PTC Therapeutics, Inc.
100 Corporate Court, Middlesex Business Center
South Plainfield, NJ 07080 / US
[2017/24]
Inventor(s)01 / Karp, Gary Mitchell
37 Cartwright Drive
Princeton Junction, NJ 08550 / US
02 / Hwang, Seongwoo
227 Suttons Lane
Edison, NJ 08817 / US
03 / Chen, Guangming
1402 Stech Drive
Bridgewater, NJ 08807 / US
04 / Almstead, Neil Gregory
25 Hageman Lane
Princeton, NJ 08540 / US
05 / Moon, Young-Choon
11 Edgewood Drive
Belle Mead, NJ 08502 / US
 [2017/24]
Representative(s)Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
[2017/24]
Application number, filing date17153046.209.04.2004
[2017/24]
Priority number, dateUS20030461988P11.04.2003         Original published format: US 461988 P
[2017/24]
Previously filed application, dateEP2016017063009.04.2004
[2017/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3178816
Date:14.06.2017
Language:EN
[2017/24]
Search report(s)(Supplementary) European search report - dispatched on:EP06.03.2017
ClassificationIPC:C07D271/06, A61P35/00, A61K31/4245
[2017/24]
CPC:
A61K31/4245 (EP,US); C07D271/06 (EP,KR,US); A61K31/4439 (EP,US);
A61K31/454 (EP,US); A61K31/4545 (EP,US); A61K31/5377 (EP,US);
A61K31/655 (EP,US); A61K45/06 (EP,US); A61K9/0053 (US);
A61K9/12 (US); A61K9/48 (US); A61P27/02 (EP,US);
C07D271/12 (EP,US); C07D285/14 (EP,US); C07D413/02 (EP,US);
C07D413/04 (EP,KR,US); C07D413/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/24]
TitleGerman:1,2,4-OXADIAZOLBENZOESÄUREVERBINDUNG UND DEREN VERWENDUNG ZUR NONSENSE-UNTERDRÜCKUNG UND BEHANDLUNG VON KRANKHEITEN[2017/24]
English:1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE[2017/24]
French:COMPOSÉ D'ACIDE BENZOÏQUE 1,2,4-OXADIAZOLE ET SON UTILISATION POUR LA SUPPRESSION NON-SENS ET LE TRAITEMENT DE MALADIES[2017/24]
Examination procedure15.12.2017Application deemed to be withdrawn, date of legal effect  [2018/27]
06.02.2018Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2018/27]
Parent application(s)   TooltipEP04759404.9  / EP1618098
EP14188816.4  / EP2910551
Divisional application(s)EP17204895.1  / EP3345895
EP19174887.0  / EP3549936
EP19209758.2  / EP3632902
EP21169137.3  / EP3889142
EP22178089.3  / EP4101846
Fees paidRenewal fee
25.01.2017Renewal fee patent year 03
25.01.2017Renewal fee patent year 04
25.01.2017Renewal fee patent year 05
25.01.2017Renewal fee patent year 06
25.01.2017Renewal fee patent year 07
25.01.2017Renewal fee patent year 08
25.01.2017Renewal fee patent year 09
25.01.2017Renewal fee patent year 10
25.01.2017Renewal fee patent year 11
25.01.2017Renewal fee patent year 12
25.01.2017Renewal fee patent year 13
02.05.2017Renewal fee patent year 14
27.04.2018Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9741105  (NIPPON SODA CO [JP], et al) [A] 1-9* the whole document *;
 [A]WO9744333  (MERCK PATENT GMBH [DE], et al) [A] 1-9 * the whole document *;
 [A]WO9921852  (NIPPON SODA CO [JP], et al) [A] 1-9 * the whole document *
by applicantUS3536809
 US3598123
 US3845770
 US3916899
 US4008719
 US4765539
 US4962885
 US5059595
 US5073543
 US5112598
 US5120548
 WO9412285
 WO9414543
 US5354556
 WO9526234
 WO9526235
 WO9532807
 US5556611
 US5591767
 US5639476
 US5674533
 WO9739745
 US5733566
 US5950619
 US5954047
 WO9947196
 US5970974
 WO0144516
    - SLEAT, EUR. J. PED. NEUROL., (2001), vol. 5, no. A, pages 57 - 62
    - BEDWELL, NAT. MED, (1997), vol. 3, pages 1280 - 1284
    - HOWARD, NAT. MED, (1996), vol. 2, pages 467 - 469
    - BARTON-DAVIS, J. CLIN. INVEST, (1999), vol. 104, pages 375 - 381
    - FREEDMAN ET AL., GASTROENTEROLOGY, (2001), vol. 121, no. 4, pages 950 - 7
    - BERNHARD, EXP LUNG RES, (2001), vol. 27, no. 4, pages 349 - 66
    - STOTLAND ET AL., PEDIATR PULMONOL, (2000), vol. 30, no. 5, pages 413 - 24
    - CONNOLLY ET AL., J NEUROIMMUNOL, (2002), vol. 127, no. 1-2, pages 80 - 7
    - GARVEY ET AL., GENOMICS, (2002), vol. 79, no. 2, pages 146 - 9
    - NAKAMURA ET AL., NEUROMUSCUL DISORD, (2001), vol. 11, no. 3, pages 251 - 9
    - NAKAMURA, NEUROMUSCUL DISORD, (2001), vol. 11, no. 3, pages 251 - 9
    - DUBOWITZ, NEUROMUSCUL DISORD, (2000), vol. 10, no. 4-5, pages 292 - 8
    - PILLERS ET AL., LARYNGOSCOPE, (1999), vol. 109, no. 8, pages 1310 - 2
    - KRAMER ET AL., NEUROMUSCUL DISORD, (1998), vol. 8, no. 8, pages 542 - 50
    - NAKAMURA ET AL., AM J PHYSIOL CELL PHYSIOL, (2001), vol. 281, no. 2, pages C690 - 9
    - SCHLENKER; BURBACH, J APPL PHYSIOL, (1991), vol. 71, no. 5, pages 1655 - 62
    - GASCHEN; BURGUNDER, ACTA NEUROPATHOL (BERL, (2001), vol. 101, no. 6, pages 591 - 600
    - FLETCHER ET AL., NEUROMUSCUL DISORD, (2001), vol. 11, no. 3, pages 239 - 43
    - VALENTINE ET AL., AM J MED GENET, (1992), vol. 42, no. 3, pages 352 - 6
    - CHAMBERLAIN; BENIAN, CURR BIOL, (2000), vol. 10, no. 21, pages R795 - 7
    - CULETTE; SATTELLE, HUM MOL GENET, (2000), vol. 9, no. 6, pages 869 - 77
    - AJI, CIRCULATION, (1997), vol. 95, no. 2, pages 430 - 7
    - FANTAPPIE, LIFE SCI, (1992), vol. 50, no. 24, pages 1913 - 24
    - RICHARDSON ET AL., ATHEROSCLEROSIS, (1998), vol. 138, no. 1, pages 135 - 46
    - HASLER-RAPACZ, AM J MED GENET, (1998), vol. 76, no. 5, pages 379 - 86
    - TSUTSUMI, ARZNEIMITTELFORSCHUNG, (2000), vol. 50, no. 2, pages 118 - 21
    - HARSCH ET AL., BR J PHARMACOL, (1998), vol. 124, no. 2, pages 227 - 82
    - TANAKA ET AL., ATHEROSCLEROSIS, (1995), vol. 114, no. 1, pages 73 - 82
    - VAIL; MACEWEN, CANCER INVEST, (2000), vol. 18, no. 8, pages 781 - 92
    - ZHANG; ROTH, IN VIVO, (1994), vol. 8, no. 5, pages 755 - 69
    - MORRIS ET AL., J LA STATE MED SOC, (1998), vol. 150, no. 4, pages 179 - 85
    - HOSOKAWA ET AL., TRANSGENIC RES, (2001), vol. 10, no. 5, pages 471 - 8
    - KADO ET AL., CANCER RES, (2001), vol. 61, no. 6, pages 2395 - 8
    - WANG, INT J PANCREATOL, (2001), vol. 29, no. 1, pages 37 - 46
    - GHANEH ET AL., GENE THER, (2001), vol. 8, no. 3, pages 199 - 208
    - BRYANT ET AL., LAB INVEST, (2000), vol. 80, no. 4, pages 553 - 73
    - HOUGH, PROC NATL ACAD SCI USA, (1998), vol. 95, no. 23, pages 13853 - 8
    - HERBER, J VIROL, (1996), vol. 70, no. 3, pages 1873 - 81
    - FODDE; SMITS, TRENDS MOL MED, (2001), vol. 7, no. 8, pages 369 - 73
    - KURAGUCHI, ONCOGENE, (2000), vol. 19, no. 50, pages 5755 - 63
    - CICHOWSKI, SEMIN CANCER BIOL, (1996), vol. 7, no. 5, pages 291 - 8
    - HOWES, INVEST OPHTHALMOL VIS SCI, (1994), vol. 35, no. 2, pages 342 - 51
    - WINDLE ET AL., NATURE, (1990), vol. 343, no. 6259, pages 665 - 9
    - NISHIDA, CURR EYE RES, (1981), vol. L, no. L, pages 53 - 5
    - KOBAYASHI ET AL., ACTA NEUROPATHOL (BERL, (1982), vol. 57, no. 2-3, pages 203 - 8
    - SCHARNHORST ET AL., CELL GROWTH DIFFER, (1997), vol. 8, no. 2, pages 133 - 43
    - MESFIN; BREECH, LAB ANIM SCI, (1996), vol. 46, no. 3, pages 321 - 6
    - MURPHY, ANTICANCER RES, (1987), vol. 7, no. 4B, pages 717 - 9
    - VOLLRATH, PROC NATL ACAD SCI USA, (2001), vol. 98, no. 22, pages 12584 - 9
    - HANITZSCH, ACTA ANAT (BASEL, (1998), vol. 162, no. 2-3, pages 119 - 26
    - JAISSLE, INVEST OPHTHALMOL VIS SCI, (2001), vol. 42, no. 2, pages 506 - 13
    - LAI, AM J PATHOL, (1980), vol. 98, no. 1, pages 281 - 4
    - KLOEHN, HORM METAB RES, (2001), vol. 33, no. 7, pages 394 - 401
    - VIERLING, BEST PRACT RES CLIN GASTROENTEROL, (2001), vol. 15, no. 4, pages 591 - 610
    - REIPERT, THROMB HAEMOST, (2000), vol. 84, no. 5, pages 826 - 32
    - JARVIS ET AL., THROMB HAEMOST, (1996), vol. 75, no. 2, pages 318 - 25
    - BI, NAT GENET, (1995), vol. 10, no. 1, pages 1 19 - 21
    - GALLO-PENN, HUM GENE THER, (1999), vol. 10, no. 11, pages 1791 - 802
    - CONNELLY, BLOOD, (1998), vol. 91, no. 9, pages 3273 - 81
    - SNYDER, NAT MED, (1999), vol. 5, no. 1, pages 64 - 70
    - WANG, PROC NATL ACAD SCI USA, (1997), vol. 94, no. 21, pages 1 1563 - 6
    - FANG, GENE THER, (1996), vol. 3, no. 3, pages 217 - 22
    - MOUNT, BLOOD, (2002), vol. 99, no. 8, pages 2670 - 6
    - KAY, PROC NATL ACAD SCI USA, (1994), vol. 91, no. 6, pages 2353 - 7
    - LOZIER, BLOOD, (1999), vol. 93, no. 6, pages 1875 - 81
    - SANDERS, LAB INVEST, (1988), vol. 59, no. 4, pages 443 - 52
    - NICHOLS, PROC NATL ACAD SCI USA, (1995), vol. 92, no. 7, pages 2455 - 9
    - JOHNSON; BOWIE, J LAB CLIN MED, (1992), vol. 120, no. 4, pages 553 - 8
    - BRINKHOUS, MAYO CLIN PROC, (1991), vol. 66, no. 7, pages 733 - 42
    - LEWIS, BLOOD, (1998), vol. 91, no. 6, pages 2152 - 6
    - RAJA, BR J HAEMATOL, (1994), vol. 86, no. 1, pages 156 - 62
    - SKOW, CELL, (1983), vol. 34, no. 3, pages 1043 - 52
    - BUSHINSKY, KIDNEY INT, (1999), vol. 55, no. 1, pages 234 - 43
    - BUSHINSKY, KIDNEY INT, (1995), vol. 48, no. 6, pages 1705 - 13
    - GRASES, SCAND J UROL NEPHROL, (1998), vol. 32, no. 4, pages 261 - 5
    - BURGESS, UROL RES, (1995), vol. 23, no. 4, pages 239 - 42
    - KUMAR, J UROL, (1991), vol. 146, no. 5, pages 1384 - 9
    - OKADA, HINYOKIKA KIYO, (1985), vol. 31, no. 4, pages 565 - 77
    - BLUESTONE, LAB INVEST, (1975), vol. 33, no. 3, pages 273 - 9
    - JONES ET AL., J UROL, (1991), vol. 145, no. 4, pages 868 - 74
    - ITATANI ET AL., INVEST UROL, (1979), vol. 17, no. 3, pages 234 - 40
    - BARLOW ET AL., PROC NATL ACAD SCI USA, (1999), vol. 96, no. 17, pages 9915 - 9
    - INOUE, CANCER RES, (1986), vol. 46, no. 8, pages 3979 - 82
    - BROOKS ET AL., PROC NATL ACAD SCI USA., (2002), vol. 99, no. 9, pages 6216 - 21
    - MONROY, BONE, (2002), vol. 30, no. 2, pages 352 - 9
    - VOGLER ET AL., PEDIATR DEV PATHOL, (2001), vol. 4, no. 5, pages 421 - 33
    - VOGLER ET AL., PEDIATR RES., (2001), vol. 49, no. 3, pages 342 - 8
    - WOLFE ET AL., MOL THER., (2000), vol. 2, no. 6, pages 552 - 6
    - MATZNER, GENE THER., (2002), vol. 9, no. L, pages 53 - 63
    - SANGO ET AL., NEUROPATHOL APPL NEUROBIOL., (2002), vol. 28, no. L, pages 23 - 34
    - BHATTACHARYYA ET AL., GLYCOBIOLOGY, (2001), vol. 11, no. 1, pages 99 - 10
    - BHAUMIK ET AL., GLYCOBIOLOGY, (1999), vol. 9, no. 12, pages 1389 - 96
    - D'HOOGE ET AL., BRAIN RES, (1999), vol. 847, no. 2, pages 352 - 6
    - D'HOOGE ET AL., NEUROSCI LETT, (1999), vol. 273, no. 2, pages 93 - 6
    - , JALANKO ET AL., HUM MOL GENET., (1998), vol. 7, no. 2, pages 265 - 72
    - CRAWLEY ET AL., J CLIN INVEST, (1998), vol. 101, no. 1, pages 109 - 19
    - NORRDIN ET AL., BONE, (1995), vol. 17, no. 5, pages 485 - 9
    - MARCH, ACTA NEUROPATHOL (BERL, (1997), vol. 94, no. 2, pages 164 - 72
    - OTTERBACH; STOFFEL, CELL, (1995), vol. 81, no. 7, pages 1053 - 6
    - JOLLY ET AL., BIRTH DEFECTS ORIG ARCTIC SER., (1975), vol. 11, no. 6, pages 273 - 8
    - KWIATKOWSKI ET AL., HUM MOL GENET., (2002), vol. 11, no. 5, pages 525 - 34
    - KOBAYASHI ET AL., PROC NATL ACAD SCI USA., (20010717), vol. 98, no. 15, pages 8762 - 7
    - HINO, NIPPON RINSHO, (2000), vol. 58, no. 6, pages 1255 - 61
    - MIZUGUCHI, J NEUROPATHOL EXP NEUROL., (2000), vol. 59, no. 3, pages 188 - 9
    - HINO, PROG EXP TUMOR RES, (1999), vol. 35, pages 95 - 108
    - ONDA, J CLIN INVEST., (1999), vol. 104, no. 6, pages 687 - 95
    - GARINIS ET AL., HUM GEN, (2002), vol. 111, pages 115 - 117
    - MEYERS, PROC. NATL. ACAD. SCI. USA, (1998), vol. 95, pages 15587 - 15591
    - KUNG ET AL., NATURE MEDICINE, (2000), vol. 6, no. 12, pages 1335 - 1340
    - MASUDA ET AL., TOKAI J EXP CLIN MED, (2000), vol. 25, no. 2, pages 69 - 77
    - OH ET AL., MOL CELLS, (2000), vol. 10, no. 3, pages 275 - 80
    - LI ET AL., LAB INVEST, (2000), vol. 80, no. 4, pages 493 - 9
    - YANG ET AL., ZHONGHUA ZHONG LIU ZA ZHI, (1999), vol. 21, no. 2, pages 114 - 8
    - FINKELSTEIN ET AL., MOL DIAGN, (1998), vol. 3, no. 1, pages 37 - 41
    - KAJIYAMA ET AL., DIS ESOPHAGUS, (1998), vol. 11, no. 4, pages 279 - 83
    - KAWAMURA ET AL., LEUK RES., (1999), vol. 23, no. 2, pages 115 - 26
    - RADIG ET AL., HUM PATHOL, (1998), vol. 29, no. 11, pages 1310 - 6
    - SCHUYER, INT J CANCER, (1998), vol. 76, no. 3, pages 299 - 303
    - WANG-GOHRKE, ONCOL REP, (1998), vol. 5, no. 1, pages 65 - 8
    - FULOP ET AL., J REPROD MED, (1998), vol. 43, no. 2, pages 119 - 27
    - NINOMIYA ET AL., J DERMATOL SCI., (1997), vol. 14, no. 3, pages 173 - 8
    - HSIEH ET AL., CANCER LETT., (1996), vol. 100, no. 1-2, pages 107 - 13
    - RAIL, PANCREAS, (1996), vol. 12, no. L, pages 10 - 7
    - FUKUTOMI ET AL., NIPPON RINSHO., (1995), vol. 53, no. 11, pages 2764 - 8
    - FREBOURG ET AL., AM J HUM GENET, (1995), vol. 56, no. 3, pages 608 - 15
    - DOVE, CANCER SURV., (1995), vol. 25, pages 335 - 55
    - ADAMSON ET AL., BR J HAEMATOL., (1995), vol. 89, no. L, pages 61 - 6
    - GRAYSON ET AL., AM J PEDIATR HEMATOL ONCOL., (1994), vol. 16, no. 4, pages 341 - 7
    - LEPELLEY ET AL., LEUKEMIA, (1994), vol. 8, no. 8, pages 1342 - 9
    - MCINTYRE ET AL., J CLIN ONCOL., (1994), vol. 12, no. 5, pages 925 - 30
    - HORIO, ONCOGENE, (1994), vol. 9, no. 4, pages 1231 - 5
    - NAKAMURA ET AL., JPN J CANCER RES., (1992), vol. 83, no. 12, pages 1293 - 8
    - DAVIDOFF ET AL., ONCOGENE, (1992), vol. 7, no. 1, pages 127 - 33
    - ISHIOKA, BIOCHEM BIOPHYS RES COMMUN, (1991), vol. 177, no. 3, pages 901 - 6
    - EUGENE BRAUNWALD ET AL.,, Harrison's Principles of Internal Medicine, 15th ed.,, (2001), pages 491 - 762
    - JENS T. CARSTENSEN, Drug Stability: Principles & Practice,2d ed.,, MARCEL DEKKER, (1995), pages 379 - 80
    - RALEIGH ET AL., PROC. AMER. ASSOC. CANCER RESEARCH ANNUAL MEETING, (1999), vol. 40, page 397
    - VERSCHOYLE ET AL., BRITISH J CANCER, (1999), vol. 80, no. 2, page 96
    - SEFTON, CRC CRIT. REF BIOMED ENG, (1987), vol. 14, page 201
    - BUCHWALD ET AL., SURGERY, (1980), vol. 88, page 507
    - SAUDEK ET AL., N. ENGL. J MED, (1989), vol. 321, page 574
    - RANGER; PEPPAS, J MACROMOL. SCI. REV. MACROMOL. CHEM., (1983), vol. 23, page 61
    - LEVY ET AL., SCIENCE, (1985), vol. 228, page 190
    - DURING ET AL., ANN. NEUROL., (1989), vol. 25, page 351
    - HOWARD ET AL., J. NEUROSURG., (1989), vol. 71, page 105
    - GOODSON, MEDICAL APPLICATIONS OF CONTROLLED RELEASE, (1984), vol. 2, page 115
    - LANGER, SCIENCE, (1990), vol. 249, page 1527
    - LIE; MACDONALD, DEVELOPMENT, (1999), vol. 126, no. 22, pages 4989 - 4996
    - LIE; MACDONALD, BIOCHEM. BIOPHYS. RES. COMMUN, (2000), vol. 270, no. 2, pages 473 - 481
    - MOAZED; NOLLER, NATURE, (1987), vol. 327, no. 6121, pages 389 - 394
    - WOODCOCK ET AL., EMBO J., (1991), vol. 10, no. 10, pages 3099 - 3103
    - SCHROEDER ET AL., EMBO J., (2000), vol. 19, pages 1 - 9
    - YANG ET AL., HUM MOL GENET, (1993), vol. 2, no. 8, pages 1253 - 1261
    - HOWARD ET AL., NAT MED., (1996), vol. 2, no. 4, pages 467 - 469
    - SICINSKI ET AL., SCIENCE, (1989), vol. 244, no. 4912, pages 1578 - 1580
    - BARTON-DAVIS ET AL., J CLIN INVEST., (1999), vol. 104, no. 4, pages 375 - 381
    - BARTON-DAVIS ET AL., J CLIN INVEST, (1999), vol. 104, no. 4, pages 375 - 381
 US20020390747
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.